Neri Flavia, Furian Lucrezia, Cavallin Francesco, Ravaioli Matteo, Silvestre Cristina, Donato Paola, La Manna Gaetano, Pinna Antonio Daniele, Rigotti Paolo
Kidney and Pancreas Transplant Unit, Department of Surgery, Oncology and Gastroenterology, Padua University Hospital, Padua, Italy.
Esophageal and Digestive Tract Surgical Unit, Veneto Institute of Oncology IOV IRCCS, Padua, Italy.
Clin Transplant. 2017 Oct;31(10). doi: 10.1111/ctr.13036. Epub 2017 Aug 20.
The aging of the on-dialysis population raises the issue of whether to propose elderly patients for kidney transplantation and how to manage their immunosuppression. This study aimed to analyze the outcome of kidney transplantation on an Italian series of elderly recipients. We included in this retrospective study all patients over 60 years, receiving a deceased-donor kidney transplantation from January 2004 to December 2014 in two north Italian Centers. We analyzed the correlation of recipient age with graft's and patient's survival, delayed graft function, acute cellular rejection (ACR), surgical complications, infections, and glomerular filtration rate. Four hundred and fifty-two patients with a median age of 65 years were included in the study. One-, 3-, and 5-year patient's and graft's survival were, respectively, of 98.7%, 93%, 89% and 94.4%, 87.9%, 81.4%. The increasing recipient age was an independent risk factor only for the patient's (P=.008) and graft's survival (P=.002). ACR and neoplasia were also associated to a worse graft survival. The reduced graft survival in elderly kidney recipients seems to be related more to the increasing recipient's age than to the donor's features. In this population, the optimization of organ allocation and immunosuppression may be the key factors to endorse improvements.
透析人群的老龄化引发了是否建议老年患者进行肾移植以及如何管理其免疫抑制的问题。本研究旨在分析意大利一组老年肾移植受者的肾移植结果。我们在这项回顾性研究中纳入了2004年1月至2014年12月期间在意大利北部两个中心接受 deceased-donor 肾移植的所有60岁以上患者。我们分析了受者年龄与移植物和患者生存率、移植肾功能延迟、急性细胞排斥反应(ACR)、手术并发症、感染以及肾小球滤过率之间的相关性。该研究纳入了452例中位年龄为65岁的患者。1年、3年和5年的患者生存率和移植物生存率分别为98.7%、93%、89%和94.4%、87.9%、81.4%。受者年龄增加仅是患者生存率(P = 0.008)和移植物生存率(P = 0.002)的独立危险因素。ACR和肿瘤形成也与较差的移植物生存率相关。老年肾移植受者移植物生存率降低似乎更多与受者年龄增加有关,而非供者特征。在这一人群中,优化器官分配和免疫抑制可能是促进改善的关键因素。